BioSpace News Archive

FARAPULSE Inc. (“FARAPULSE” or “the Company”) today announced the U.S. Food and Drug Administration (FDA) conditionally approved the Company’s Investigational Device Exemption (IDE) application to initiate its U.S. pivotal ADVENT trial to evaluate the safety and effectiveness of its Pulsed Field Ablation (PFA) system for the treatment of paroxysmal Atrial Fibrillation (AF)

Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products in women’s health, today announced that it is expanding the availability of COVID-19 RT-PCR testing across the United States to support the rising demand for testing

Merus N.V. (Nasdaq: MRUS), and Sema4, a patient-centered health intelligence company, today announced they have entered into a strategic agreement to utilize Sema4’s advanced genomic testing to identify patients with tumors harboring neuregulin 1 gene (NRG1) fusions who may be eligible for investigational treatment with the bispecific antibody Zenocutuzumab (“Zeno”) in the Phase 1/2 eNRGy trial sponsored by Merus.

Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today announced the initiation of its global Phase 3 pivotal trial, ASSERT, Alagille Syndrome looking at Safety and Efficacy in a Randomized controlled Trial, which will evaluate odevixibat in patients with Alagille syndrome

Medicure Inc. announced that Medicure Pharma Inc., it entered into a definitive agreement on December 15, 2020, to acquire 100% of Marley Drug, Inc, a leading specialty pharmacy serving more than 30,000 customers across the United States, from an arms-length third-party, for an upfront payment on closing of USD $6.3 million, subject to certain holdbacks, as well as additional payments based on future performance of Marley.

Dr. Sandhya Rao has joined Blue Cross Blue Shield of Massachusetts as chief medical officer. Prior to joining Blue Cross, Dr. Rao was vice president of clinical strategy at Haven, the organization formed by Amazon, JP Morgan Chase and Berkshire Hathaway.

Diameter Health, a fast-growing leader in health data interoperability, has announced that it raised $18 million in a Series B funding round led by managed care organization Centene Corporation, with participation from existing investors Optum Ventures, LRVHealth, Connecticut Innovations and Activate Venture Partners.

Tivity Health, Inc. (NASDAQ: TVTY) today announced that it will participate in the virtual 39 th Annual J.P. Morgan Healthcare Conference, which will include a presentation by Richard Ashworth , President & Chief Executive Officer, followed by a question and answer session including Adam Holland , Chief Financial Officer,

Poseida Therapeutics, Inc. (NASDAQ: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary gene engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced the appointment of Luke Corning, Portfolio Manager and Head of Credit at Pentwater Capital Management, to its Board of Directors.

On behalf of the National Kidney Foundation and the American Society of Nephrology, we thank the trainees, clinicians, and the public—particularly people with kidney diseases, kidney failure, and kidney transplants—for their ongoing support of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases.